[Long-term immunosuppressive treatment of progressive chronic polyarthritis and lupus erythematosus].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008231:Lymphopenia / Q000209:etiology; D008297:Male; D008875:Middle Aged; D012217:Rheumatoid Factor; D013921:Thrombocytopenia / Q000209:etiology
D000305:Adrenal Cortex Hormones; D012217:Rheumatoid Factor; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001379:Azathioprine
Ergebnisse der immunsuppressiven Langzeitbehandlung der progressiv chronischen Polyarthritis und des Lupus erythematodes.